These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25477316)

  • 1. Spontaneous control of HIV-1 viremia in a subject with protective HLA-B plus HLA-C alleles and HLA-C associated single nucleotide polymorphisms.
    Moroni M; Ghezzi S; Baroli P; Heltai S; De Battista D; Pensieroso S; Cavarelli M; Dispinseri S; Vanni I; Pastori C; Zerbi P; Tosoni A; Vicenzi E; Nebuloni M; Wong K; Zhao H; McHugh S; Poli G; Lopalco L; Scarlatti G; Biassoni R; Mullins JI; Malnati MS; Alfano M
    J Transl Med; 2014 Dec; 12():335. PubMed ID: 25477316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired Nef function is associated with early control of HIV-1 viremia.
    Kuang XT; Li X; Anmole G; Mwimanzi P; Shahid A; Le AQ; Chong L; Qian H; Miura T; Markle T; Baraki B; Connick E; Daar ES; Jessen H; Kelleher AD; Little S; Markowitz M; Pereyra F; Rosenberg ES; Walker BD; Ueno T; Brumme ZL; Brockman MA
    J Virol; 2014 Sep; 88(17):10200-13. PubMed ID: 24965469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.
    Emu B; Sinclair E; Hatano H; Ferre A; Shacklett B; Martin JN; McCune JM; Deeks SG
    J Virol; 2008 Jun; 82(11):5398-407. PubMed ID: 18353945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-B*57 and IFNL4-related polymorphisms are associated with protection against HIV-1 disease progression in controllers.
    Dominguez-Molina B; Tarancon-Diez L; Hua S; Abad-Molina C; Rodriguez-Gallego E; Machmach K; Vidal F; Tural C; Moreno S; Goñi JM; Ramírez de Arellano E; Del Val M; Gonzalez-Escribano MF; Del Romero J; Rodriguez C; Capa L; Viciana P; Alcamí J; Yu XG; Walker BD; Leal M; Lichterfeld M; Ruiz-Mateos E;
    Clin Infect Dis; 2017 Mar; 64(5):621-628. PubMed ID: 27986689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy.
    Pereyra F; Addo MM; Kaufmann DE; Liu Y; Miura T; Rathod A; Baker B; Trocha A; Rosenberg R; Mackey E; Ueda P; Lu Z; Cohen D; Wrin T; Petropoulos CJ; Rosenberg ES; Walker BD
    J Infect Dis; 2008 Feb; 197(4):563-71. PubMed ID: 18275276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy.
    Hatano H; Delwart EL; Norris PJ; Lee TH; Dunn-Williams J; Hunt PW; Hoh R; Stramer SL; Linnen JM; McCune JM; Martin JN; Busch MP; Deeks SG
    J Virol; 2009 Jan; 83(1):329-35. PubMed ID: 18945778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1.
    Tang J; Tang S; Lobashevsky E; Myracle AD; Fideli U; Aldrovandi G; Allen S; Musonda R; Kaslow RA;
    J Virol; 2002 Aug; 76(16):8276-84. PubMed ID: 12134033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-Bw4-B*57 and Cw*18 alleles are associated with plasma viral load modulation in HIV-1 infected individuals in Salvador, Brazil.
    Silva EM; Acosta AX; Santos EJ; Netto EM; Lemaire DC; Oliveira AS; Barbosa CM; Bendicho MT; Galvão-Castro B; Brites C
    Braz J Infect Dis; 2010; 14(5):468-75. PubMed ID: 21221475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of HIV-1 nef and gag Variations and Host HLA Characteristics as Determinants of Disease Progression among HIV-1 Vertically Infected Kenyan Children.
    Saina MC; Bi X; Lihana R; Lwembe R; Ishizaki A; Panikulam A; Palakudy T; Musoke R; Owens M; Songok EM; Ichimura H
    PLoS One; 2015; 10(8):e0137140. PubMed ID: 26317223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the Polymorphism
    Herráiz-Nicuesa L; Hernández-Flórez DC; Valor L; García-Consuegra S; Navarro-Valdivieso JP; Fernández-Cruz E; Rodríguez-Sainz C
    J Immunol Res; 2017; 2017():8689313. PubMed ID: 29445759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-operative additive effects between HLA alleles in control of HIV-1.
    Matthews PC; Listgarten J; Carlson JM; Payne R; Huang KH; Frater J; Goedhals D; Steyn D; van Vuuren C; Paioni P; Jooste P; Ogwu A; Shapiro R; Mncube Z; Ndung'u T; Walker BD; Heckerman D; Goulder PJ
    PLoS One; 2012; 7(10):e47799. PubMed ID: 23094091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-APOBEC3G activity of HIV-1 Vif protein is attenuated in elite controllers.
    Kikuchi T; Iwabu Y; Tada T; Kawana-Tachikawa A; Koga M; Hosoya N; Nomura S; Brumme ZL; Jessen H; Pereyra F; Trocha A; Walker BD; Iwamoto A; Tokunaga K; Miura T
    J Virol; 2015 May; 89(9):4992-5001. PubMed ID: 25717111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy.
    Hunt PW; Brenchley J; Sinclair E; McCune JM; Roland M; Page-Shafer K; Hsue P; Emu B; Krone M; Lampiris H; Douek D; Martin JN; Deeks SG
    J Infect Dis; 2008 Jan; 197(1):126-33. PubMed ID: 18171295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel association of five HLA alleles with HIV-1 progression in Spanish long-term non progressor patients.
    Ramírez de Arellano E; Díez-Fuertes F; Aguilar F; de la Torre Tarazona HE; Sánchez-Lara S; Lao Y; Vicario JL; García F; González-Garcia J; Pulido F; Gutierrez-Rodero F; Moreno S; Iribarren JA; Viciana P; Vilches C; Ramos M; Capa L; Alcamí J; Del Val M
    PLoS One; 2019; 14(8):e0220459. PubMed ID: 31393887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity.
    Flores-Villanueva PO; Yunis EJ; Delgado JC; Vittinghoff E; Buchbinder S; Leung JY; Uglialoro AM; Clavijo OP; Rosenberg ES; Kalams SA; Braun JD; Boswell SL; Walker BD; Goldfeld AE
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5140-5. PubMed ID: 11309482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of protective HCP5 and HLA-C associated polymorphisms in the control of HIV-1 replication in a subset of elite suppressors.
    Han Y; Lai J; Barditch-Crovo P; Gallant JE; Williams TM; Siliciano RF; Blankson JN
    AIDS; 2008 Feb; 22(4):541-4. PubMed ID: 18301071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
    Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL
    J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 Controller.
    Walker-Sperling VE; Pohlmeyer CW; Veenhuis RT; May M; Luna KA; Kirkpatrick AR; Laeyendecker O; Cox AL; Carrington M; Bailey JR; Arduino RC; Blankson JN
    EBioMedicine; 2017 Feb; 16():141-149. PubMed ID: 28159573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isotype-switched immunoglobulin G antibodies to HIV Gag proteins may provide alternative or additional immune responses to 'protective' human leukocyte antigen-B alleles in HIV controllers.
    French MA; Center RJ; Wilson KM; Fleyfel I; Fernandez S; Schorcht A; Stratov I; Kramski M; Kent SJ; Kelleher AD
    AIDS; 2013 Feb; 27(4):519-28. PubMed ID: 23364441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.